+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
PRISMMEDI PRISMMEDI

Prism Medico and Pharmacy Share Price

₹32.94 -0.06 (-0.18%)
New 52W High in past week

22 Oct, 2026 4:01 PM (IST)

Prism Medico and Pharmacy live price: ₹32.94. It opened at ₹34 vs previous close ₹33; intraday high/low: ₹34/₹31. The 50 & 200 DMA stand at ₹29.80/₹26.90.

Prism Medico and Pharmacy Performance

  • Today's Low
  • ₹31
  • Today's High
  • ₹34
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹35
  • Open Price₹34
  • Previous Close₹33
  • Volume9,480
  • 50 DMA₹29.80
  • 100 DMA₹28.90
  • 200 DMA₹26.90

Prism Medico and Pharmacy Chart

Investment Returns

  • Over 1 Month + 7.89%
  • Over 3 Month + 20.53%
  • Over 6 Month + 3.29%
  • Over 1 Year + 57.01%

Smart Investing Starts Here Start SIP with Prism Medico and Pharmacy for Steady Growth!

Invest Now

Prism Medico and Pharmacy Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -112.4
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 45
  • P/B Ratio
  • 2
  • Average True Range
  • 2.4
  • EPS
  • -0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.9
  • RSI
  • 54.13
  • MFI
  • 66.02

Latest Stock News Updates

Prism Medico and Pharmacy Ltd - 512217 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find attached the confirmation certificate issues by RTA for the quarter ended 30th September, 2026. You are requested to kindly take the same on record and oblige. Thanking you.

Prism Medico and Pharmacy Ltd - 512217 - Compliance-57 (5) : intimation after the end of quarter

Dear Sir/ Madam Pursuant to Regulation 57(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), please find the attached Intimation for the quarter on 30th September, 2026. You are requested to kindly take the same on record and oblige. Thanking you.

Prism Medico and Pharmacy Ltd - 512217 - Compliance-57 (4) : Prior intimation to the beginning of the quarter

Dear Sir/ Madam, Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements), Regulations, 2015 (LODR), please find the attached intimation. You are requested to kindly take the same on record and oblige. Thanking you.

Prism Medico and Pharmacy Financials

Prism Medico and Pharmacy Technicals

EMA & SMA

Current Price
₹32.94
-0.06 (-0.18%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹30.80
  • 50 Day
  • ₹29.80
  • 100 Day
  • ₹28.90
  • 200 Day
  • ₹26.90

Resistance and Support

32.68 Pivot Speed
  • R3 35.50
  • R2 34.70
  • R1 33.00
  • S1 30.40
  • S2 29.60
  • S3 27.90

Prism Medico and Pharmacy Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-24 Others
2026-08-12 Quarterly Results
2026-05-28 Audited Results
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results

Prism Medico and Pharmacy Shareholding Pattern

70.02%
29.98%
0%

About Prism Medico and Pharmacy

Prism Medico and Pharmacy is an Indian public-listed company engaged in trading, financial investments, and basic chemical and agricultural product View More
  • NSE Symbol
  • PRISMMEDI
  • BSE Symbol
  • 512217
  • ISIN
  • INE730E01016

Similar Stocks to Prism Medico and Pharmacy

Prism Medico and Pharmacy FAQs

Prism Medico and Pharmacy share price is ₹32 As on 23 October, 2026 | 08:17

The Market Cap of Prism Medico and Pharmacy is ₹44.7 Cr As on 23 October, 2026 | 08:17

The P/E ratio of Prism Medico and Pharmacy is -112.4 As on 23 October, 2026 | 08:17

The PB ratio of Prism Medico and Pharmacy is 2 As on 23 October, 2026 | 08:17

The 52 week High & Low of Prism Medico and Pharmacy is ₹34.8/₹15.5 respectively As on 23 October, 2026 | 08:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23